1-9 of 9
Dawen Sui
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Daratumumab-Based Maintenance in Patients with Relapsed Multiple Myeloma after Salvage Autologous Hematopoietic Stem Cell Transplantation

Oren Pasvolsky, Krina K. Patel, Qaiser Bashir, Mikael Rauf, Dawen Sui, Samer A. Srour, Mark R. Tanner, Uday R. Popat, Neeraj Y. Saini, Chitra Hosing, Jeremy Ramdial, Elisabet E. Manasanch, Hans C. Lee, Gregory P. Kaufman, Sheeba K. Thomas, Donna M. Weber, Melody R. Becnel, Guilin Tang, Robert Z. Orlowski, Dipa Patel, Richard E. Champlin, Yago Nieto, Elizabeth J. Shpall, Muzaffar H. Qazilbash
Journal: Blood
Blood (2023) 142 (Supplement 1): 7070.
https://doi.org/10.1182/blood-2023-189109
Published: 2023
Journal Articles

Phase 1/2 Trial to Jointly Optimize Dose and Administration Schedule of Evomela in Newly Diagnosed Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation

Qaiser Bashir, Peter Thall, Dawen Sui, Jitesh Kawedia, Cristina Knape, Ruby Delgado, Jandi L Schindler, Uday R. Popat, Partow Kebriaei, Chitra Hosing, Issa F. Khouri, Yago Nieto, Betul Oran, Samer A. Srour, Neeraj Y. Saini, Amanda L. Olson, Sairah Ahmed, Gheath Alatrash, Gabriela Rondon, Hans C. Lee, Sheeba K. Thomas, Elisabet E. Manasanch, Krina K. Patel, Robert Z. Orlowski, Richard E. Champlin, Elizabeth J. Shpall, Muzaffar H. Qazilbash
Journal: Blood
Blood (2023) 142 (Supplement 1): 4972.
https://doi.org/10.1182/blood-2023-189844
Published: 2023
Journal Articles

TP53 copy number and protein expression inform mutation status across risk categories in acute myeloid leukemia

Mehrnoosh Tashakori, Tapan Kadia, Sanam Loghavi, Naval Daver, Rashmi Kanagal-Shamanna, Sherry Pierce, Dawen Sui, Peng Wei, Farnoosh Khodakarami, Zhenya Tang, Mark Routbort, Carol A. Bivins, Elias J. Jabbour, L. Jeffrey Medeiros, Kapil Bhalla, Hagop M. Kantarjian, Farhad Ravandi, Joseph D. Khoury
Journal: Blood
Blood (2022) 140 (1): 58–72.
https://doi.org/10.1182/blood.2021013983
Published: 2022
Includes: Supplemental data
Journal Articles

A Prospective Phase I/II Trial to Jointly Optimize the Administration Schedule and Dose of Melphalan for Injection (Evomela) As a Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma

Qaiser Bashir, Peter F. Thall, Dawen Sui, Jeremy L. Ramdial, Samer A. Srour, Rohtesh S. Mehta, Uday R. Popat, Yago Nieto, Neeraj Saini, Partow Kebriaei, Elisabet E. Manasanch, Hans C. Lee, Gregory P. Kaufman, Sheeba K Thomas, Krina K. Patel, Robert Z. Orlowski, Cristina G. Knape, Jitesh D. Kawedia, Richard E. Champlin, Elizabeth J. Shpall, Xiaoqian Liu, Muzaffar H. Qazilbash
Journal: Blood
Blood (2021) 138 (Supplement 1): 3941.
https://doi.org/10.1182/blood-2021-149807
Published: 2021
Journal Articles

Trial in Progress: A Prospective Phase I/II Trial to Jointly Optimize the Administration Schedule(s) and Dose(s) of Melphalan for Injection (Evomela) As a Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma

Qaiser Bashir, MD, Peter F Thall, PhD, Dawen Sui, Cristina Knape, Jitesh Kawedia, BPharm, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-139853
Published: 2020
Journal Articles

Outcome of Multiple Myeloma with Chromosome 1q Gain and 1p Deletion after High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation

Ankur Varma, MD, Neeraj Y Saini, MD, Dawen Sui, Denái R. Milton, Omar Hasan, Akash Mukherjee, MD, Qaiser Bashir, MD MBBS, Gabriela Rondon, MD, Samer A. Srour, MD, Uday Popat, MD, Chitra Hosing, MD, Yago Nieto, MD PhD, Partow Kebriaei, MD, Amin M. Alousi, MD, Rohtesh S. Mehta, MD MPH, MS, Issa F. Khouri, Donna M. Weber, MD, Sheeba K. Thomas, MD, Elisabet E. Manasanch, MD, Hans C. Lee, MD, Krina K. Patel, MD MSc, Stefan O. Ciurea, Elizabeth J. Shpall, MD, Robert Z Orlowski, MD PhD, Richard E Champlin, MD, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4609.
https://doi.org/10.1182/blood-2018-99-115457
Published: 2018
Journal Articles

In-Vivo Purging with Rituximab (R) Followed By Z/BEAM Vs BEAM/R Autologous Stem Cell Conditioning for Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) Patients (pts): Mature Results from a Combined Analysis of 3 Trials

Issa F. Khouri, Dawen Sui, Francesco Turturro, MD, William D Erwin, Roland L Bassett, Jr., Martin Korbling, Rosamar Valverde, Sairah Ahmed, Amin M. Alousi, MD, Paolo Anderlini, Qaiser Bashir, MD, Stefan O. Ciurea, MD, Betul Oran, MD, Amanda Olson, Uday R. Popat, MD, Krina K Patel, Muzaffar H. Qazilbash, MD, Michelle A. Fanale, Luis E. Fayad, MD, Loretta Nastoupil, MD, Jason R Westin, MD, Alison M Gulbis, L. Jeffrey Medeiros, Ken H. Young, Aaron Jessop
Journal: Blood
Blood (2015) 126 (23): 3192.
https://doi.org/10.1182/blood.V126.23.3192.3192
Published: 2015
Journal Articles

Prognostic Factors, Staging and Treatments in Advanced Stage Mycosis Fungoides and Sézary Syndrome

Rakhshandra Talpur, MD, Silvia Alberti-Violetti, MD, Megan Schilti, Dawen Sui, MS, Madeleine Duvic, MD
Journal: Blood
Blood (2014) 124 (21): 1673.
https://doi.org/10.1182/blood.V124.21.1673.1673
Published: 2014
Journal Articles

Linezolid Use in Hematopoietic Stem Cell Transplantation: A Cautionary Tale

Alison M Gulbis, PharmD, Musa Yilmaz, MD, Dawen Sui, MS, Roland L Bassett, Jr., MS, Zandra R Rivera, RN, MS, ANP-BC, Richard E. Champlin, Marcos De Lima, MD
Journal: Blood
Blood (2012) 120 (21): 4534.
https://doi.org/10.1182/blood.V120.21.4534.4534
Published: 2012